 | • レポートコード：GIR-2104Z14334 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腸チフスワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腸チフスワクチンの種類別市場規模（経口タイプ、注射タイプ）、用途別市場規模（病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腸チフスワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Merck、GlaxoSmithKline、PaxVax、Actiza Pharmaceutical、Merit Pharmaceuticals、Bharat Biotec ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口タイプ、注射タイプ ・用途別分析2016年-2026年：病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、その他 ・腸チフスワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腸チフスワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腸チフスワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腸チフスワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腸チフスワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Typhoid Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Typhoid Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Typhoid Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Typhoid Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Type
Injection Type
Market segment by Application can be divided into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
The key market players for global Typhoid Vaccine market are listed below:
Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Typhoid Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Typhoid Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Typhoid Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Global Typhoid Vaccine Market Size & Forecast
1.4.1 Global Typhoid Vaccine Sales in Value (2016-2026))
1.4.2 Global Typhoid Vaccine Sales in Volume (2016-2026)
1.4.3 Global Typhoid Vaccine Price by Type (2016-2026) & (USD/Unit)
1.5 Global Typhoid Vaccine Production Capacity Analysis
1.5.1 Global Typhoid Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Typhoid Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Typhoid Vaccine Market Drivers
1.6.2 Typhoid Vaccine Market Restraints
1.6.3 Typhoid Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Typhoid Vaccine Product and Services
2.1.4 Sanofi Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Typhoid Vaccine Product and Services
2.2.4 Merck Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Typhoid Vaccine Product and Services
2.3.4 GlaxoSmithKline Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 PaxVax
2.4.1 PaxVax Details
2.4.2 PaxVax Major Business
2.4.3 PaxVax Typhoid Vaccine Product and Services
2.4.4 PaxVax Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Actiza Pharmaceutical
2.5.1 Actiza Pharmaceutical Details
2.5.2 Actiza Pharmaceutical Major Business
2.5.3 Actiza Pharmaceutical Typhoid Vaccine Product and Services
2.5.4 Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Merit Pharmaceuticals
2.6.1 Merit Pharmaceuticals Details
2.6.2 Merit Pharmaceuticals Major Business
2.6.3 Merit Pharmaceuticals Typhoid Vaccine Product and Services
2.6.4 Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Bharat Biotec
2.7.1 Bharat Biotec Details
2.7.2 Bharat Biotec Major Business
2.7.3 Bharat Biotec Typhoid Vaccine Product and Services
2.7.4 Bharat Biotec Typhoid Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Typhoid Vaccine Sales by Manufacturer
3.1 Global Typhoid Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Typhoid Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Typhoid Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Typhoid Vaccine Manufacturer Market Share
3.4.2 Top 6 Typhoid Vaccine Manufacturer Market Share
3.5 Global Typhoid Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Typhoid Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Typhoid Vaccine Market Size by Region
4.1.1 Global Typhoid Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Typhoid Vaccine Revenue by Region (2016-2026)
4.2 North America Typhoid Vaccine Revenue (2016-2026)
4.3 Europe Typhoid Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Typhoid Vaccine Revenue (2016-2026)
4.5 South America Typhoid Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Typhoid Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Typhoid Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Typhoid Vaccine Revenue by Type (2016-2026)
5.3 Global Typhoid Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Typhoid Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Typhoid Vaccine Revenue by Application (2016-2026)
6.3 Global Typhoid Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Typhoid Vaccine Sales by Type (2016-2026)
7.2 North America Typhoid Vaccine Sales by Application (2016-2026)
7.3 North America Typhoid Vaccine Market Size by Country
7.3.1 North America Typhoid Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Typhoid Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Typhoid Vaccine Sales by Type (2016-2026)
8.2 Europe Typhoid Vaccine Sales by Application (2016-2026)
8.3 Europe Typhoid Vaccine Market Size by Country
8.3.1 Europe Typhoid Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Typhoid Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Typhoid Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Typhoid Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Typhoid Vaccine Market Size by Region
9.3.1 Asia-Pacific Typhoid Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Typhoid Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Typhoid Vaccine Sales by Type (2016-2026)
10.2 South America Typhoid Vaccine Sales by Application (2016-2026)
10.3 South America Typhoid Vaccine Market Size by Country
10.3.1 South America Typhoid Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Typhoid Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Typhoid Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Typhoid Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Typhoid Vaccine Market Size by Country
11.3.1 Middle East & Africa Typhoid Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Typhoid Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Typhoid Vaccine Typical Distributors
12.3 Typhoid Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Typhoid Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Typhoid Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Typhoid Vaccine Product and Services
Table 6. Sanofi Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Typhoid Vaccine Product and Services
Table 10. Merck Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Typhoid Vaccine Product and Services
Table 14. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. PaxVax Basic Information, Manufacturing Base and Competitors
Table 16. PaxVax Major Business
Table 17. PaxVax Typhoid Vaccine Product and Services
Table 18. PaxVax Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Actiza Pharmaceutical Major Business
Table 21. Actiza Pharmaceutical Typhoid Vaccine Product and Services
Table 22. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Merit Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Merit Pharmaceuticals Major Business
Table 25. Merit Pharmaceuticals Typhoid Vaccine Product and Services
Table 26. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Bharat Biotec Basic Information, Manufacturing Base and Competitors
Table 28. Bharat Biotec Major Business
Table 29. Bharat Biotec Typhoid Vaccine Product and Services
Table 30. Bharat Biotec Typhoid Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Typhoid Vaccine Sales by Manufacturer (2019-2021e) & (K Units)
Table 32. Global Typhoid Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Typhoid Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Typhoid Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Typhoid Vaccine Production Site of Key Manufacturer
Table 36. Global Typhoid Vaccine Sales by Region (2016-2021e) & (K Units)
Table 37. Global Typhoid Vaccine Sales by Region (2021-2026) & (K Units)
Table 38. Global Typhoid Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Typhoid Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 41. Global Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. Global Typhoid Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Typhoid Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Typhoid Vaccine Price by Type (2016-2021e) & (USD/Unit)
Table 45. Global Typhoid Vaccine Price by Type (2021-2026) & (USD/Unit)
Table 46. Global Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 47. Global Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 48. Global Typhoid Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Typhoid Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Typhoid Vaccine Price by Application (2016-2021e) & (USD/Unit)
Table 51. Global Typhoid Vaccine Price by Application (2021-2026) & (USD/Unit)
Table 52. North America Typhoid Vaccine Sales by Country (2016-2021e) & (K Units)
Table 53. North America Typhoid Vaccine Sales by Country (2021-2026) & (K Units)
Table 54. North America Typhoid Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Typhoid Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 57. North America Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 58. North America Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 59. North America Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 60. Europe Typhoid Vaccine Sales by Country (2016-2021e) & (K Units)
Table 61. Europe Typhoid Vaccine Sales by Country (2021-2026) & (K Units)
Table 62. Europe Typhoid Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Typhoid Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 65. Europe Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 66. Europe Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 67. Europe Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 68. Asia-Pacific Typhoid Vaccine Sales by Region (2016-2021e) & (K Units)
Table 69. Asia-Pacific Typhoid Vaccine Sales by Region (2021-2026) & (K Units)
Table 70. Asia-Pacific Typhoid Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Typhoid Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 73. Asia-Pacific Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 74. Asia-Pacific Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 75. Asia-Pacific Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 76. South America Typhoid Vaccine Sales by Country (2016-2021e) & (K Units)
Table 77. South America Typhoid Vaccine Sales by Country (2021-2026) & (K Units)
Table 78. South America Typhoid Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Typhoid Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 81. South America Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 82. South America Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 83. South America Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 84. Middle East & Africa Typhoid Vaccine Sales by Country (2016-2021e) & (K Units)
Table 85. Middle East & Africa Typhoid Vaccine Sales by Country (2021-2026) & (K Units)
Table 86. Middle East & Africa Typhoid Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Typhoid Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Typhoid Vaccine Sales by Type (2016-2021e) & (K Units)
Table 89. Middle East & Africa Typhoid Vaccine Sales by Type (2021-2026) & (K Units)
Table 90. Middle East & Africa Typhoid Vaccine Sales by Application (2016-2021e) & (K Units)
Table 91. Middle East & Africa Typhoid Vaccine Sales by Application (2021-2026) & (K Units)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Typhoid Vaccine Typical Distributors
Table 95. Typhoid Vaccine Typical Customers
List of Figures
Figure 1. Typhoid Vaccine Picture
Figure 2. Global Typhoid Vaccine Sales Market Share by Type in 2020
Figure 3. Oral Type
Figure 4. Injection Type
Figure 5. Global Typhoid Vaccine Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Research & Academic Laboratories
Figure 8. Pharmaceutical & Biotechnology Companies
Figure 9. Others
Figure 10. Global Typhoid Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Typhoid Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Typhoid Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Typhoid Vaccine Sales (2016-2026) & (K Units)
Figure 32. Global Typhoid Vaccine Production Capacity (2016-2026) & (K Units)
Figure 33. Global Typhoid Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Typhoid Vaccine Market Drivers
Figure 35. Typhoid Vaccine Market Restraints
Figure 36. Typhoid Vaccine Market Trends
Figure 37. Global Typhoid Vaccine Sales Market Share by Manufacturer in 2020
Figure 38. Global Typhoid Vaccine Revenue Market Share by Manufacturer in 2020
Figure 39. Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Typhoid Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Typhoid Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Typhoid Vaccine Sales Market Share by Region (2016-2026)
Figure 43. Global Typhoid Vaccine Revenue Market Share by Region (2016-2026)
Figure 44. North America Typhoid Vaccine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Typhoid Vaccine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Typhoid Vaccine Revenue (2016-2026) & (USD Million)
Figure 47. South America Typhoid Vaccine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Typhoid Vaccine Revenue (2016-2026) & (USD Million)
Figure 49. Global Typhoid Vaccine Sales Market Share by Type (2016-2026)
Figure 50. Global Typhoid Vaccine Revenue Market Share by Type (2016-2026)
Figure 51. Global Typhoid Vaccine Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 53. Global Typhoid Vaccine Revenue Market Share by Application (2016-2026)
Figure 54. Global Typhoid Vaccine Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Typhoid Vaccine Sales Market Share by Country (2016-2026)
Figure 56. North America Typhoid Vaccine Revenue Market Share by Country (2016-2026)
Figure 57. North America Typhoid Vaccine Sales Market Share by Type (2016-2026)
Figure 58. North America Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 59. Europe Typhoid Vaccine Sales Market Share by Country (2016-2026)
Figure 60. Europe Typhoid Vaccine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Typhoid Vaccine Sales Market Share by Type (2016-2026)
Figure 62. Europe Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Typhoid Vaccine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Typhoid Vaccine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Typhoid Vaccine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 67. South America Typhoid Vaccine Sales Market Share by Country (2016-2026)
Figure 68. South America Typhoid Vaccine Revenue Market Share by Country (2016-2026)
Figure 69. South America Typhoid Vaccine Sales Market Share by Type (2016-2026)
Figure 70. South America Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Typhoid Vaccine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Typhoid Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Typhoid Vaccine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Typhoid Vaccine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の経口コレラワクチン市場 2021：企業別、地域別、種類・用途別 The Oral Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別 The Cholera Vaccine (Oral Route) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の新型コロナウイルス感染症RNAワクチン市場規模・現状・予測（2021年-2027年） RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, us…
- 世界の新型コロナウイルス感染症DNAワクチン市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 DNA Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 DNA Vaccine status, future forecast, growth opportunity, key market, and key play…
- 世界の新型コロナウイルス感染症組換えタンパク質ワクチン市場規模・現状・予測（2021年-2027年） Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-ol…